vs
CollPlant Biotechnologies Ltd（CLGN）与ESTABLISHMENT LABS HOLDINGS INC.（ESTA）财务数据对比。点击上方公司名可切换其他公司
ESTABLISHMENT LABS HOLDINGS INC.的季度营收约是CollPlant Biotechnologies Ltd的361.0倍（$64.6M vs $179.0K）。ESTABLISHMENT LABS HOLDINGS INC.同比增速更快（45.2% vs -28.1%）
CollPlant Biotechnologies是一家再生医疗企业，依托专有的植物源人胶原蛋白技术，开发并商业化伤口护理、软组织修复、医美领域的创新产品，主要面向北美、欧洲及以色列市场，服务皮肤科、骨科和医美领域的医疗从业者。
Establishment Labs Holdings Inc.是一家总部位于美国的无晶圆厂半导体企业，同时专注于人工智能领域业务，核心为数据中心及AI基础设施研发高速连接解决方案，于2024年3月在纳斯达克挂牌上市。
CLGN vs ESTA — 直观对比
营收规模更大
ESTA
是对方的361.0倍
$179.0K
营收增速更快
ESTA
高出73.3%
-28.1%
损益表 — Q2 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $179.0K | $64.6M |
| 净利润 | $-3.3M | — |
| 毛利率 | -3.9% | 70.5% |
| 营业利润率 | -1775.4% | -6.1% |
| 净利率 | -1869.8% | — |
| 营收同比 | -28.1% | 45.2% |
| 净利润同比 | 20.5% | — |
| 每股收益（稀释后） | $0.28 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLGNESTA
| Q4 25 | — | $64.6M | ||
| Q3 25 | — | $53.8M | ||
| Q2 25 | $179.0K | $51.3M | ||
| Q1 25 | — | $41.4M | ||
| Q4 24 | — | $44.5M | ||
| Q3 24 | — | $40.2M | ||
| Q2 24 | $249.0K | $44.1M | ||
| Q1 24 | — | $37.2M |
净利润CLGNESTA
| Q4 25 | — | — | ||
| Q3 25 | — | $-11.1M | ||
| Q2 25 | $-3.3M | $-16.6M | ||
| Q1 25 | — | $-20.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-16.7M | ||
| Q2 24 | $-4.2M | $-17.2M | ||
| Q1 24 | — | $-16.2M |
毛利率CLGNESTA
| Q4 25 | — | 70.5% | ||
| Q3 25 | — | 70.1% | ||
| Q2 25 | -3.9% | 68.8% | ||
| Q1 25 | — | 67.2% | ||
| Q4 24 | — | 68.5% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | -115.3% | 65.6% | ||
| Q1 24 | — | 65.6% |
营业利润率CLGNESTA
| Q4 25 | — | -6.1% | ||
| Q3 25 | — | -7.5% | ||
| Q2 25 | -1775.4% | -27.5% | ||
| Q1 25 | — | -41.0% | ||
| Q4 24 | — | -41.9% | ||
| Q3 24 | — | -32.7% | ||
| Q2 24 | -1769.5% | -21.2% | ||
| Q1 24 | — | -23.8% |
净利率CLGNESTA
| Q4 25 | — | — | ||
| Q3 25 | — | -20.7% | ||
| Q2 25 | -1869.8% | -32.3% | ||
| Q1 25 | — | -50.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -41.5% | ||
| Q2 24 | -1690.8% | -38.9% | ||
| Q1 24 | — | -43.6% |
每股收益（稀释后）CLGNESTA
| Q4 25 | — | $-0.07 | ||
| Q3 25 | — | $-0.38 | ||
| Q2 25 | $0.28 | $-0.57 | ||
| Q1 25 | — | $-0.70 | ||
| Q4 24 | — | $-1.21 | ||
| Q3 24 | — | $-0.59 | ||
| Q2 24 | $0.37 | $-0.62 | ||
| Q1 24 | — | $-0.58 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.4M | $75.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.5M | $23.5M |
| 总资产 | $17.4M | $357.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLGNESTA
| Q4 25 | — | $75.6M | ||
| Q3 25 | — | $70.6M | ||
| Q2 25 | $11.4M | $54.6M | ||
| Q1 25 | — | $69.2M | ||
| Q4 24 | — | $90.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | $18.9M | — | ||
| Q1 24 | — | — |
总债务CLGNESTA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CLGNESTA
| Q4 25 | — | $23.5M | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | $12.5M | $22.8M | ||
| Q1 25 | — | $38.5M | ||
| Q4 24 | — | $53.1M | ||
| Q3 24 | — | $32.7M | ||
| Q2 24 | $20.7M | $45.0M | ||
| Q1 24 | — | $56.9M |
总资产CLGNESTA
| Q4 25 | — | $357.2M | ||
| Q3 25 | — | $338.9M | ||
| Q2 25 | $17.4M | $329.7M | ||
| Q1 25 | — | $333.4M | ||
| Q4 24 | — | $346.8M | ||
| Q3 24 | — | $282.7M | ||
| Q2 24 | $26.6M | $285.1M | ||
| Q1 24 | — | $301.8M |
负债/权益比CLGNESTA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-162.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-2.0M |
| 自由现金流率自由现金流/营收 | — | -3.1% |
| 资本支出强度资本支出/营收 | — | 2.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-56.9M |
8季度趋势，按日历期对齐
经营现金流CLGNESTA
| Q4 25 | — | $-162.0K | ||
| Q3 25 | — | $-11.3M | ||
| Q2 25 | — | $-18.8M | ||
| Q1 25 | — | $-20.7M | ||
| Q4 24 | — | $-20.7M | ||
| Q3 24 | — | $-12.5M | ||
| Q2 24 | — | $-14.2M | ||
| Q1 24 | — | $-11.2M |
自由现金流CLGNESTA
| Q4 25 | — | $-2.0M | ||
| Q3 25 | — | $-13.1M | ||
| Q2 25 | — | $-20.4M | ||
| Q1 25 | — | $-21.5M | ||
| Q4 24 | — | $-21.3M | ||
| Q3 24 | — | $-13.9M | ||
| Q2 24 | — | $-15.0M | ||
| Q1 24 | — | $-14.5M |
自由现金流率CLGNESTA
| Q4 25 | — | -3.1% | ||
| Q3 25 | — | -24.4% | ||
| Q2 25 | — | -39.7% | ||
| Q1 25 | — | -51.9% | ||
| Q4 24 | — | -47.8% | ||
| Q3 24 | — | -34.6% | ||
| Q2 24 | — | -33.9% | ||
| Q1 24 | — | -38.9% |
资本支出强度CLGNESTA
| Q4 25 | — | 2.8% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 1.2% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 1.8% | ||
| Q1 24 | — | 8.9% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
